Funded
Funded

Immunai

Founded: 2020

Immunai is mapping the immune system at single-cell resolution using AI and multi-omics data. Their platform accelerates drug discovery and development, unlocking new insights for immunotherapy and precision medicine

Ownership status:
Privately held
Headquarters location:
United States
  • Artificial intelligence
  • Medicine
  • Science
Artificial intelligence
Medicine
Science

Company Overview

Immunai uses AI and single-cell biology to map the immune system. iAngels gives investors early access to cutting-edge biotech like Immunai.

Founders and Management

Noam Solomon

Co-Founder and CEO

Luis Voloch

Co-Founder

More Opportunities

company bg

BeeHero

BeeHero is transforming commercial pollination with precision agriculture powered by in-hive sensors and AI. Their platform helps growers boost crop yields while supporting bee health—solving a critical challenge in global food production.

Learn more
company bg

Guardz

Guardz provides cyber protection for small businesses through an all-in-one security platform. With automated tools for email, devices, and data, they help SMBs stay protected without the need for a dedicated IT team.

Learn more
company bg

eToro

Founded in 2007, eToro is a global trading platform that blends traditional assets with crypto and a unique social investing experience. Users can mirror top investors and trade with ease. The company has submitted papers for an IPO, marking a major milestone in its growth.

Learn more

Exclusive for iAngels

Join for free and be notified of future investment opportunities

Immunai in the news

05.15.2023 | BusinessWire

Immunai and Baylor College of Medicine Provide Updated Interim Phase 1 Results

Read Read article
Noam Solomon | 01.04.2022 | THE JERUSALEM POST

Can Israel become a global biotech leader?

Read Read article
Heather McKenzie | 09.09.2021 | BioSpace

Where AI and Immunotherapy Converge to Reprogram Immunity

Read Read article

FAQ

iAngels offers accredited investors access to early-stage biotech companies specializing in areas like immunogenomics.

As a private company, Immunai may offer investment opportunities during funding rounds. iAngels provides access to such biotech opportunities.

Investing in immunogenomics supports personalized medicine and novel therapies, addressing unmet medical needs with strong return potential.

Similar Companies

company bg

Beach Bum

Beach Bum develops top-grossing social mobile games that bring classic board and card games into the digital age. With a focus on design, engagement, and monetization, they’ve built a loyal global user base and strong recurring revenue across platforms.In 2021, the company was acquired by Voodoo, a global leader in mobile gaming

Learn more
company bg

Bitmain

Bitmain is a global leader in cryptocurrency mining hardware, known for its Antminer product line. Its ASIC technology powers large-scale blockchain operations, playing a key role in the Bitcoin ecosystem

Learn more
company bg

eToro

Founded in 2007, eToro is a global trading platform that blends traditional assets with crypto and a unique social investing experience. Users can mirror top investors and trade with ease. The company has submitted papers for an IPO, marking a major milestone in its growth.

Learn more

Exclusive for iAngels

Join for free and be notified of future investment opportunities

Skip to content